跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,768 条关于
“mEGFR Tyrosine Kinase Inhibitor”
全部
22,768
临床试验
11,761
药物
4,401
机构
29
资讯
6,577
去年
Jubilant Therapeutics Initiates Global Clinical Trials for JBI-802 and JBI-778 in Oncology
去年
Jubilant Therapeutics Initiates Clinical Trials for JBI-802 and JBI-778 in Oncology
去年
Jubilant Therapeutics Initiates Global Clinical Trials for JBI-802 and JBI-778
去年
ESK981 Plus Nivolumab Fails to Show Antitumor Activity in Metastatic Castration-Resistant Prostate Cancer
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
上个月
Non-Tyrosine Kinase Inhibitors Market to Reach USD 18.7 Billion by 2036, Driven by Biomarker-Linked Oncology Approvals
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Significantly Improve Outcomes in Advanced Breast Cancer
第 1 页，共 658 页
上一页
下一页
